This transition aims to modernize the healthcare supply chain by improving traceability, reducing administrative errors, and providing patients with real-time medical information.
While some regions have already mandated electronic labeling, others currently utilize a hybrid model that combines digital features with traditional paper inserts. Technologies like Digital Display Labels are especially transformative in clinical trials, as they allow for instantaneous updates to dosage and safety data without the need for manual relabeling.
Ultimately, these digital innovations foster a more patient-centric approach by enhancing treatment adherence and streamlining the delivery of essential medicines.
Follow this podcast on your favorite streaming platform - links can be found by clicking here.
